Re:BioNTech alone could lift German economy by 0.5% this year
by suction on Tuesday August 10, 2021 @12:11PM
(#28130613)
Pfizer surely did help monetarily (investments) and offers global distribution, but that doesn't mean they had any hand in developing the science and the product.
Any big pharmaceutical company, like Bayer, could have done the same, but randomly Pfizer got lucky this time.
Re:BioNTech alone could lift German economy by 0.5% this year
by spywaregorilla on Tuesday August 10, 2021 @01:01PM
(#28131268)
Pfizer played a major role in the trials, which is an enormous part of the process.
Re:BioNTech alone could lift German economy by 0.5% this year
by suction on Wednesday August 11, 2021 @02:17AM
(#28138665)
Which, again, any big pharmaceutical company would have offered to a drug developer, and was in no way a special attribute of Pfizer.
Re:BioNTech alone could lift German economy by 0.5% this year
by spywaregorilla on Wednesday August 11, 2021 @11:21AM
(#28143068)
I mean yeah, but it's still a large complicated task. I don't think executing major projects like this should be handwaved because there's alternative options.
This is equivalent to saying there's nothing special about biontech as any specialist in novel MRNA vaccines could have developed these. Which did happen, at moderna.
Re:BioNTech alone could lift German economy by 0.5% this year
by kken on Tuesday August 10, 2021 @12:37PM
(#28130954)
They started working together even before Covid.
https://biontech.de/sites/default/files/2019-08/20180816_Bio...
The Pfizer head of vaccine research seems to be from Germany as well.
Re:BioNTech alone could lift German economy by 0.5% this year
by skybrian on Tuesday August 10, 2021 @12:31PM
(#28130883)
That’s discounting the difficulty of manufacturing these new vaccines, which only a few companies know how to do, and also required many subcontractors.
If it were easy, it wouldn’t have taken so long to scale up manufacturing, even by the largest pharmaceutical companies.
It may help to know that Pfizer directly helped with the development - not just the manufacturing & distribution - and deserves some credit as well (even if not as much as BioNTech).
From their March 27, 2020 co-development press release:
"Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine"
"Builds on 2018 agreement to jointly develop an mRNA-based influenza vaccine"
"The collaboration aims to accelerate development of BioNTech’s potential first-in-class COVID-19 mRNA vaccine program, BNT162, which is expected to enter clinical testing by the end of April 2020. The rapid advancement of this collaboration builds on the research and development collaboration into which Pfizer and BioNTech entered in 2018 to develop mRNA-based vaccines for prevention of influenza."